Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Deborah Collyar: What's In It for Patients?

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Advertisement

Advertisement




Jun
30
Today In Oncology
I Miss My Life
AACR Cancer Disparities Progress Report Mortality Rates Improve But Care Inequities Persist
Fertility Preservation Access Remains Limited and Unequal for Many Girls and Young Women With Cancer
Adverse Events With CD3-Based T-Cell–Engaging Bispecific Antibody Treatment in Cancer
Survey Results Show Patients Prefer Learning of a Diagnosis From Their Doctor Rather Than a Health Portal
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo